Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_assertion type Assertion NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_head.
- NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_assertion description "[We listed the upregulated genes based on the TE4:TE2 expression ratio, such as c-Src, Jak-1, and sialyltransferase, which are expected to be target pathways as well as the downregulated genes, including CASP8 and CASP10, after Ad-FHIT treatment in esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_provenance.
- NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_assertion evidence source_evidence_literature NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_provenance.
- NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_assertion SIO_000772 19120899 NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_provenance.
- NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_assertion wasDerivedFrom befree-2016 NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_provenance.
- NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_assertion wasGeneratedBy ECO_0000203 NP712217.RAdLgk8OJDa1fC2oRcYY2MB9-UoxgZvMkE05zKQCOK3Sc130_provenance.